oseltamivir has been researched along with Respiratory Syncytial Virus Infections in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 8 (80.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Bont, LJ; Löwensteyn, YN | 1 |
Cárdenas, AM; Chang, YC; Feemster, K; Mitchell, SL | 1 |
Chung, JW; Jang, KH; Lee, SH; Moon, JD; Park, WJ; Yoo, SJ | 1 |
Cummins, A; Millership, S | 1 |
Heikkinen, T | 1 |
Berger, A; Christopeit, M; Hauf, E; Hentrich, M; Heussel, CP; Kalkreuth, J; Klein, M; Kochanek, M; Lehners, N; Mayer, K; Penack, O; Rieger, C; Schalk, E; Silling, G; Vehreschild, M; von Lilienfeld-Toal, M; Weber, T; Wolf, HH | 1 |
Ariza-Heredia, EJ; Chemaly, RF; Shahani, L | 1 |
Brydak, LB; Donevski, S; Gawryluk, D; Romanowska, M; Stefanska, I | 1 |
Alba, A; Álvarez, AM; Catalán, P; Zubleta, M | 1 |
Chi, MH; Goleniewska, K; Higginbotham, JN; Moore, ML; O'Neal, JF; Peebles, RS; Zhou, W | 1 |
3 review(s) available for oseltamivir and Respiratory Syncytial Virus Infections
Article | Year |
---|---|
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.
Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Community-Acquired Infections; Cytosine; Germany; Hand Hygiene; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Influenza, Human; Lung; Masks; Medical Oncology; Metapneumovirus; Neoplasms; Neuraminidase; Nucleic Acid Amplification Techniques; Organophosphonates; Oseltamivir; Paramyxoviridae Infections; Patient Isolation; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Tomography, X-Ray Computed; Virus Diseases | 2016 |
Antiviral therapy for respiratory viral infections in immunocompromised patients.
Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Coronavirus Infections; Cyclopentanes; Guanidines; Humans; Immunocompromised Host; Influenza, Human; Oseltamivir; Palivizumab; Paramyxoviridae Infections; Picornaviridae Infections; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Zanamivir | 2017 |
[Prophylaxis against respiratory viral disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
Topics: Adenoviridae Infections; Adult; Antiviral Agents; Child; Drug Administration Schedule; Humans; Incidence; Influenza, Human; Organ Transplantation; Oseltamivir; Paramyxoviridae Infections; Postoperative Complications; Practice Guidelines as Topic; Respiratory Syncytial Virus Infections; Risk Factors; Stem Cell Transplantation | 2012 |
7 other study(ies) available for oseltamivir and Respiratory Syncytial Virus Infections
Article | Year |
---|---|
Clinical Development of Respiratory Syncytial Virus Antivirals-What We Can Learn From Oseltamivir.
Topics: Antiviral Agents; Double-Blind Method; Hematopoietic Stem Cell Transplantation; Humans; Oseltamivir; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Transplant Recipients | 2020 |
Implementation of a rapid influenza A/B and RSV direct molecular assay improves emergency department oseltamivir use in paediatric patients.
Topics: Antiviral Agents; Child; Child Health; Child, Preschool; Emergency Service, Hospital; Female; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Male; Molecular Diagnostic Techniques; Nasopharynx; Oseltamivir; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Sensitivity and Specificity; Treatment Outcome; Virus Diseases | 2018 |
Respiratory Syncytial Virus Outbreak in the Basic Military Training Camp of the Republic of Korea Air Force
Topics: Adolescent; Adult; Antiviral Agents; Body Temperature; Disease Outbreaks; Humans; Male; Military Personnel; Multiplex Polymerase Chain Reaction; Oseltamivir; Pharynx; Republic of Korea; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; RNA, Viral; Sputum; Young Adult | 2015 |
Oseltamivir in influenza outbreaks in care homes: challenges and benefits of use in the real world.
Topics: Antiviral Agents; Cost-Benefit Analysis; Databases, Factual; Disease Outbreaks; England; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Nasal Mucosa; Oseltamivir; Paramyxoviridae Infections; Picornaviridae Infections; Polymerase Chain Reaction; Post-Exposure Prophylaxis; Residential Facilities; Respiratory Syncytial Virus Infections; Retrospective Studies; Rhinovirus | 2015 |
Respiratory viruses and children.
Topics: Antiviral Agents; Bacterial Infections; Child; Child, Preschool; Cost of Illness; Humans; Influenza, Human; Oseltamivir; Otitis Media; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Viral Vaccines; Virus Diseases | 2016 |
Co-infections with influenza and other respiratory viruses.
Topics: Adult; Aged; Alphainfluenzavirus; Antiviral Agents; Child, Preschool; Coinfection; Coronavirus; Coronavirus Infections; Female; Humans; Immunocompromised Host; Influenza, Human; Male; Middle Aged; Oseltamivir; Parainfluenza Virus 3, Human; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections | 2013 |
Cutting Edge: Oseltamivir decreases T cell GM1 expression and inhibits clearance of respiratory syncytial virus: potential role of endogenous sialidase in antiviral immunity.
Topics: Animals; Antiviral Agents; CD8-Positive T-Lymphocytes; Down-Regulation; Female; G(M1) Ganglioside; Immunity, Cellular; Lymphocyte Activation; Membrane Microdomains; Mice; Mice, Inbred BALB C; Neuraminidase; Oseltamivir; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Signal Transduction | 2007 |